Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Oneview HealthcareASX:ONE 37 3-Year EPS without NRI Growth Rate is 2.20% as of Jun. 2026, which is 93% below its 10-year median of 30.00. GuruFocus rates ASX:ONE with a GF Score™ of 37/100 and a GF Value™ of A$0.39 (Possible Value Trap). The stock has 5 warning signs investors should review. Among 503 Healthcare Providers & Services companies, Oneview Healthcare ranks worse than 62.82% on this metric.
During the past 3 years, the average EPS without NRI Growth Rate was 2.20% per year.
During the past 5 years, the average EPS without NRI Growth Rate was 14.00% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.
During the past 10 years, the highest 3-Year average EPS without NRI Growth Rate of Oneview Healthcare was 59.70% per year. The lowest was 2.20% per year. And the median was 30.00% per year.
Oneview Healthcare (ASX:ONE) 3-Year EPS without NRI Growth Rate Explanation
EPS without NRI is the amount of earnings without non-recurring items per outstanding share of the company's stock.
Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists Earnings per share without Non-Recurring Items, which better reflects the company's underlying performance.
Oneview Healthcare 3-Year EPS without NRI Growth Rate Related Terms
ASX:ONE vs VEEV, BTSG, TEM: 3-Year EPS without NRI Growth Rate Comparison
For the Health Information Services subindustry, Oneview Healthcare's 3-Year EPS without NRI Growth Rate, along with its competitors' market caps and 3-Year EPS without NRI Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Oneview Healthcare 3-Year EPS without NRI Growth Rate vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Oneview Healthcare's 3-Year EPS without NRI Growth Rate distribution charts can be found below:
* The bar in red indicates where Oneview Healthcare's 3-Year EPS without NRI Growth Rate falls into.
Oneview Healthcare 3-Year EPS without NRI Growth Rate Calculation
This is the 3-year average growth rate of EPS without NRI. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.
What does a 3-Year EPS without NRI Growth Rate of 2.20% mean?
Oneview Healthcare (ASX:ONE) has a 3-Year EPS without NRI Growth Rate of 2.20% as of Jun. 2026. 3-Year EPS without NRI Growth Rate is the 3-year average growth rate of EPS without NRI. View historical data for Oneview Healthcare and its competitors. This is 93% below median its historical median of 30.00. Over the past decade, Oneview Healthcare's 3-Year EPS without NRI Growth Rate has ranged from 2.20 to 59.70. According to the industry distribution chart, Oneview Healthcare ranks #316 out of 503 companies in the Healthcare Providers & Services industry, placing it in the top 62.8%.
Is Oneview Healthcare's 3-Year EPS without NRI Growth Rate too high?
Oneview Healthcare's current 3-Year EPS without NRI Growth Rate of 2.20% is 93% below median its 10-year median of 30.00. Over the past 10 years, this metric has ranged from a low of 2.20 to a high of 59.70. The Healthcare Providers & Services industry median 3-Year EPS without NRI Growth Rate is 11.00. Oneview Healthcare's value of 2.20% is 80% below this industry median. Based on the distribution chart, Oneview Healthcare ranks #316 out of 503 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Oneview Healthcare has a GF Score™ of 37/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Oneview Healthcare's 3-Year EPS without NRI Growth Rate compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Oneview Healthcare ranks #316 out of 503 companies for 3-Year EPS without NRI Growth Rate. This places Oneview Healthcare in the lower half of its industry. The industry median 3-Year EPS without NRI Growth Rate is 11.00. Oneview Healthcare's value of 2.20% is 80% below this benchmark. Historically, Oneview Healthcare's own 3-Year EPS without NRI Growth Rate has ranged from 2.20 to 59.70 over the past decade. While the company's 10-year median is 30.00 vs. the industry median of 11.00, Oneview Healthcare has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year EPS without NRI Growth Rate for a Healthcare Providers & Services company?
The median 3-Year EPS without NRI Growth Rate among Healthcare Providers & Services companies is 11.00, based on 503 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year EPS without NRI Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year EPS without NRI Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Oneview Healthcare's current 3-Year EPS without NRI Growth Rate of 2.20% is 80% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year EPS without NRI Growth Rate mean?
A high 3-Year EPS without NRI Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year EPS without NRI Growth Rate is the 3-year average growth rate of EPS without NRI. View historical data for Oneview Healthcare and its competitors. For the Healthcare Providers & Services industry, the median 3-Year EPS without NRI Growth Rate is 11.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Oneview Healthcare's current 3-Year EPS without NRI Growth Rate is 2.20%, which is 93% below median its own 10-year median of 30.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Oneview Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Oneview Healthcare (ASX:ONE) is currently considered Possible Value Trap. The stock's GF Value™ is A$0.39, compared to a current price of A$0.17 — trading 56.4% below its estimated fair value. The current 3-Year EPS without NRI Growth Rate is 2.20%, which is 93% below median its 10-year median of 30.00 and 80% below the Healthcare Providers & Services industry median of 11.00. Oneview Healthcare's overall GF Score™ is 37/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year EPS without NRI Growth Rate calculated?
3-Year EPS without NRI Growth Rate is calculated from a company's financial statements. For Oneview Healthcare (ASX:ONE), the current 3-Year EPS without NRI Growth Rate is 2.20% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Oneview Healthcare (ASX:ONE) Overvalued in 2026?
Based on GuruFocus' analysis, Oneview Healthcare stock appears to be undervalued.
The current stock price of A$0.17 is trading 56.4% below its estimated GF Value™ of A$0.39.
GuruFocus considers Oneview Healthcare to be Possible Value Trap.
Key valuation signals for ASX:ONE:
3-Year EPS without NRI Growth Rate: 2.20% (93% below median its 10-year median of 30.00)
GF Value™: A$0.39 vs. price of A$0.17 (56.4% below fair value)
Industry Position: 80% below the Healthcare Providers & Services median (#316 of 503)
No single metric tells the full story. See the ASX:ONE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Oneview Healthcare PLC provides patient engagement and clinical workflow technology solutions to healthcare facilities. It serves hospitals and healthcare systems, academic medical centers, and pediatric hospitals. Oneview Healthcare's Care Experience Platform (CXP) provides a unified set of digital tools in a single bedside solution and connects patients, families, and care teams with services, education, and information during hospital stays. The company operates in one reportable segment, which provides a patient engagement solution for the healthcare sector.
37GF Score
Get the complete analysis for ASX:ONE
3-Year EPS without NRI Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:ONE has been successfully added to your 
